Vance Thompson Vision
16
3
3
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
12.5%
2 terminated/withdrawn out of 16 trials
81.8%
-4.7% vs industry average
25%
4 trials in Phase 3/4
22%
2 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Exploring Sedation Types During Cataract Surgery
Role: lead
The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma
Role: lead
Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery
Role: lead
Evaluate the TetraLens, a Tetracaine Releasing Therapeutic Bandage Contact Lens in Patients Undergoing PRK Procedure
Role: lead
Efficacy of Kera Sol Tears on Signs and Symptoms of Surgical Temporary Ocular Discomfort Syndrome (STODS) in Subjects Following LASIK
Role: lead
Refractive and Visual Outcomes With the ARGOS Biometer In Eyes With a History of Refractive Surgery: ARGOS Study
Role: lead
In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery
Role: lead
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
Role: lead
The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study
Role: lead
Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)
Role: lead
Vivity Outcomes in Patients With Early Stage Glaucoma
Role: lead
Effect of Negative Pressure on Pattern Electroretinography Readings
Role: lead
Binocular Custom Vision Utilizing The Light Adjustable Lens (LAL)
Role: lead
Analysis of Defocus Curve of Pre-Presbyopic and Emerging Presbyopic Patients
Role: lead
Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification
Role: lead
DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery
Role: lead
All 16 trials loaded